Closed-Loop Centesis Systems Market

The global closed-loop centesis systems market is projected to total USD 0.48 billion in 2026, advancing to USD 1.34 billion by 2036, achieving a high compound annual growth rate of 10.7%. This expansion is driven by the critical need to improve the safety, efficiency, and patient comfort of routine fluid drainage procedures for conditions like malignant effusions and decompensated cirrhosis.

Summary of Closed-LoopCentesis Systems Market

• Market Snapshot
  • Globalclosed-loopcentesissystems market revenue stood at USD 0.48 billion in 2026 and is forecast to reach USD 1.34 billion by 2036.
  • At a 10.7%CAGRfrom 2026 to 2036, this market is set to expand ~2.8x in value, adding USD 0.86 billion in absolute opportunity.
  • Growth is driven by the increasing need to improve safety, efficiency, and patient comfort in fluid drainage procedures, particularly for conditions such as malignant effusions and decompensated cirrhosis.
  • These systems are evolving into standardized, safety-engineered clinical tools, replacing traditional manual drainage methods with controlled, closed-loop solutions.
• Demand and Growth Drivers
  • Rising prevalence of fluid accumulation conditions (pleural effusion, ascites) is increasing procedural volumes.
  • Strong shift toward infection-controlled and closed-system drainage solutions is accelerating adoption.
  • Growing emphasis on patient comfort and reduced procedural complications is reinforcing demand for vacuum-assisted systems.
  • Expansion of hospital and outpatient procedural capacity is supporting market growth.
  • Increasing adoption of integrated, ready-to-usecentesiskits is improving workflow efficiency and clinical outcomes.
• Product and Segment View
  • Vacuum-assisted systems hold 58.8% of system type share in 2026,emergingas the leading segment due to superior control over fluid removal and safety.
  • Thoracentesis accounts for 56.7% of application share in 2026, positioning it as the dominant segment driven by high procedural demand in respiratory conditions.
  • Hospitalsrepresent72.5% of end-user share in 2026, reflecting theircentral rolein performingcentesisprocedures.
  • Key system categories include:
    • Vacuum-assisted systems
    • Gravity-based systems
    • Hybrid systems
• Geography and Competitive Outlook
  • Growth is supported globally, with strong acceleration in emerging healthcare systems and expanding clinical infrastructure.
  • India (14.9%CAGR), China (14.7%), Brazil (14.2%), United States (13.7%), United Kingdom (12.0%), and Germany (11.8%) are key growth markets.
  • Market expansion is closely tied to transition from manual techniques to integrated, safety-driven medical systems, alongside increasing procedural volumes.
  • Key companies active in this market include
    • Merit Medical,
    • AngioDynamics,
    • Cook Medical,
    • Becton, Dickinson and Company (BD), and
    • Argon Medical.

Closed-LoopCentesis Systems Market — At a Glance

The market is defined by the dominance of vacuum-assisted systems, which hold a 58.8% share due to their controlled fluid removal capabilities, primarily used in thoracentesis applications that constitute 56.7 % of the market. Hospitals are the central end-user, accounting for 72.5% of demand. Geographically, the highest growth is concentrated in rapidly developing healthcare systems, with India leading at a projected 14.9 % CAGR, followed by China at 14.7 %, Brazil at 14.2%, and the USA at 13.7%. Germany and the UK show strong growth at 11.8% and 12.0% respectively. This market evolution signifies a shift from traditional manual techniques to integrated, safety-engineered systems that minimize infection risk, optimize clinician workflow, and support the increasing volume of these procedures in both inpatient and outpatient settings.

By Systems Type, Which Technology Offers the Greatest Procedural Control?

Vacuum-assisted systems command a dominant 58.8 % share. This preference is due to their ability to provide consistent, physician-controlled negative pressure, enabling predictable and efficient fluid removal while minimizing the risk of complications such as re-expansion pulmonary edema in thoracentesis or hypotension in paracentesis. Their controlled environment is considered the standard for safety in higher-acuity settings.

By Application, Which Procedure is the Most Common for Effusion Management?

Thoracentesis is the leading application with a 56.7 % share. The drainage of pleural effusions, often related to cancer, heart failure, or infection, represents a high-volume interventional procedure.

The immediate symptomatic relief it provides and the need for diagnostic fluid analysis create consistent, recurrent demand, establishing it as the primary driver for closed-loop system utilization.

By End User, Where are the Majority of Complex Drainage Procedures Performed?

Hospitals constitute the primary end-user segment at 72.5 %. These facilities manage the most complex patients, those with large-volume effusions, co-morbidities, or requiring concurrent care.

The concentration of interventional radiologists and pulmonologists, along with the need for stringent sterile technique, centralizes the adoption and use of these systems within hospital procedure units and emergency departments.

How does the USA's Advanced Interventional Radiology Practice Drive Adoption?

The USA's 13.7% CAGR is fueled by the high standardization of care in interventional radiology and pulmonary departments, where closed-loop systems are embedded in clinical guidelines for safe thoracentesis and paracentesis.

The volume of oncology-related effusions, strong reimbursement, and a focus drives growth on reducing procedure-related complications and hospital readmissions, making these systems a cost-effective standard.

What Factors Underpin China's Rapid Uptake of Standardized Procedural Kits?

China's 14.7% CAGR is driven by the rapid modernization of its hospital interventional departments and a growing emphasis on procedural safety and standardization. As cancer care expands, the demand for efficient effusion management grows.

The market is characterized by the adoption of vacuum-assisted systems in major urban hospitals, with domestic manufacturers also developing competitive offerings to serve this need.

How is India's Healthcare Infrastructure Growth Influencing Market Expansion?

India's leading 14.9% CAGR is propelled by the significant expansion of its tertiary care hospital network and the growing specialization in interventional pulmonology and radiology.

Increasing diagnosis rates of tuberculosis, cancer, and cardiac diseases that cause effusions are generating procedural demand. Growth is focused on introducing safer, more efficient technology to improve outcomes in high-volume, often resource-constrained settings.

Why does Brazil's Unified Health System Focus Create Specific Demand?

Brazil's 14.2% CAGR is linked to the focus of its public health system on standardizing and improving the quality of high-volume procedures like thoracentesis. Efforts to reduce post-procedure complications and length of stay in crowded hospitals make closed-loop systems an attractive investment. The high burden of diseases such as tuberculosis and congestive heart failure further underpins consistent procedural volume.

What Characterizes Adoption in the Protocol-Driven Markets of Germany and the UK?

Germany's 11.8% and the UK's 12.0% CAGRs reflect growth in markets where adoption is driven by clinical evidence and protocol. These health systems prioritize technologies that demonstrably reduce risks like pneumothorax or infection.

Growth is steady, fueled by replacement cycles and the integration of these systems into national and hospital-level clinical guidelines for effusion management, ensuring their use becomes a routine standard of care.

The competitive landscape features established interventional and diagnostic device companies competing on system innovation, clinical evidence, and distribution strength. Competition centers on developing integrated solutions that offer clear workflow advantages, enhanced safety features, and cost-effectiveness.

Success depends on securing key opinion leader endorsements, demonstrating superior clinical outcomes in reducing complications, and forming strong partnerships with hospital procurement groups. The market sees ongoing innovation in system ergonomics, safety needle designs, and the development of specialized kits for different clinical applications.

• British Thoracic Society. (2025). BTS Guideline for Pleural Procedures. Thorax.
• Feller-Kopman, D., & Light, R. (2024). Pleural Disease: A Clinical Guide. Springer.
• National Comprehensive Cancer Network. (2024). NCCN Clinical Practice Guidelines in Oncology: Palliative Care. NCCN.
• Rahman, N. M., & Maskell, N. A. (2024). Advances in the management of pleural disease. The Lancet Respiratory Medicine, 12(5), 401-415.
• Society of Interventional Radiology. (2025). Quality Improvement Guidelines for Image-Guided Percutaneous Drainage/Aspiration of Abscesses and Fluid Collections. Journal of Vascular and Interventional Radiology.

• Systems Type :

  • Vacuum-assisted Systems
  • Gravity-based Systems
  • Hybrid Systems

• Application :

  • Thoracentesis
  • Paracentesis

• End User :

  • Hospitals
  • ASCs
  • Clinics

• Region :

  • North America

    • USA
    • Canada

  • Latin America

    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America

  • Western Europe

    • Germany
    • France
    • Italy
    • Spain
    • UK
    • BENELUX
    • Rest of Western Europe

  • Eastern Europe

    • Russia
    • Poland
    • Czech Republic
    • Rest of Eastern Europe

  • East Asia

    • China
    • Japan
    • South Korea
    • Rest of East Asia

  • South Asia & Pacific

    • India
    • ASEAN
    • Australia
    • Rest of South Asia & Pacific

  • MEA

    • GCC Countries
    • South Africa
    • Turkiye
    • Rest of MEA